Clinical trial

This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical…

NCT00479596 · Urological Sciences Research Foundation, Other · Unknown status

Key facts

NCT number NCT00479596
Title This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo.
Official title Safety and Efficacy Study of Intradetrusor Injections of Botox® for the Treatment of Urinary Incontinence Secondary to Benign Prostatic Obstruction (BTX0621)
Acronym BTX0621
Lead sponsor Urological Sciences Research Foundation, Other
Collaborators Allergan Industry
Status Unknown status
Phase Phase 2/Phase 3
Study type Interventional
Conditions Overactive Bladder
Intervention type Drug
Interventions Botox
Enrollment 40
Start date Jan 1, 2007
Completion May 1, 2007
First posted May 28, 2007
Last update posted May 30, 2007
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 FDA inspections linked to this trial
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies